• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by FOXO Technologies Inc.

    10/23/24 5:25:11 PM ET
    $FOXO
    Life Insurance
    Finance
    Get the next $FOXO alert in real time by email
    false --12-31 0001812360 0001812360 2024-10-18 2024-10-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date Earliest Event Reported): October 18, 2024

     

    FOXO TECHNOLOGIES INC.

    (Exact name of registrant as specified in its charter)

     

    Delaware   001-39783   85-1050265
    (State or Other Jurisdiction
    of Incorporation)
      (Commission
    File Number)
      (IRS Employer
    Identification No.)

     

    729 N. Washington Ave., Suite 600
    Minneapolis, MN
      55401
    (Address of Principal Executive Offices)   (Zip Code)

     

    (612) 562-9447

    (Registrant’s telephone number, including area code)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Class A Common Stock, par value $0.0001   FOXO   NYSE American

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     
     

     

    Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

     

    On October 18, 2024, FOXO Technologies Inc., a Delaware corporation (the “Company”), filed an amendment to the Company’s Certificate of Incorporation (the “Certificate of Incorporation”), in the form of a Certificate of Designation (the “Designation”) that authorized for issuance of up to 35,000 shares of a new series of Preferred Stock, par value $0.0001 per share, of the Company designated “Series A Cumulative Convertible Redeemable Preferred Stock” (the “Series A Preferred Stock”) and established the rights, preferences and limitations thereof. The Board authorized the Series A Preferred Stock pursuant to the authority given to the Board under the Certificate of Incorporation, which authorizes the issuance of up to 10,000,000 shares of Preferred Stock, par value $0.0001 per share, and authorizes the Board, by resolution, to establish any or all of the unissued shares of Preferred Stock, not then allocated to any series into one or more series and to fix and determine the designation of each such shares, the number of shares which shall constitute such series and certain preferences, limitations and relative rights of the shares of each series so established.

     

    Voting Rights

     

    The Company shall not, without the affirmative vote of the holders of a majority of the then outstanding shares of the Series A Preferred Stock:

     

      (i) Alter or change adversely the powers, preferences or rights given to the Series A Preferred Stock or alter or amend the Certificate of Designation;
         
      (ii) Amend its Certificate of Incorporation or other charter documents in any manner that adversely affects any rights of the holders;
         
      (iii) Increase the number of authorized shares of Preferred Stock;
         
      (iv) Create or authorize the creation of, or issue or obligate itself to issue, any class or series of capital stock, unless the same ranks junior to the Series A Preferred Stock with respect to the distribution of assets on the liquidation, dissolution or winding up of the Company, the payment of dividends and rights of redemption;
         
      (v) Reclassify, alter or amend any existing security of the Company that is junior to the Series A Preferred Stock with respect to the distribution of assets on the liquidation, dissolution or winding up of the Company, the payment of dividends or rights of redemption, if such reclassification, alteration or amendment would render such security senior or pari passu with the Series A Preferred Stock in respect of any such right, preference or privilege;
         
      (vi) Purchase, redeem or otherwise acquire (or permit any subsidiary to purchase, redeem or otherwise acquire) any shares of preferred stock of the Company, or otherwise pay to or make available for a sinking fund any money for the redemption of any such shares (other than the Preferred Stock pursuant to the redemption provisions in Section 9 of the Certificate of Designation); or
         
      (vii) Enter into any agreement with respect to any of the foregoing.

     

    The holders of shares of Series A Preferred Stock, the holders of Common Stock and the holders of any other class or series of shares entitled to vote with the Common Stock shall vote together as one class on all matters submitted to a vote of stockholders of the Company. In any such vote, each share of Series A Preferred Stock shall entitle the holder thereof to cast the number of votes determined by dividing the Stated Value of such share of Series A Preferred Stock by the higher of $0.01 (such dollar amount being subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the original issue date) or the VWAP of the trading day immediately prior to the record date of the vote; provided, however, that, prior to the receipt of approval as may be required by the applicable rules and regulations of the NYSE American (or any successor entity) from the stockholders of the Company with respect to the issuance of the Conversion Shares and voting rights (the “Stockholder Approval”), the Series A Preferred Stock beneficially owned by the holders or any of their respective affiliates may only be voted to the extent that the aggregate voting power of all of the Company’s voting stock that is beneficially owned by the holders and their respective affiliates does not exceed 19.99% of the aggregate voting power of all of the Company’s voting stock outstanding on the applicable record date for determining stockholders who may vote with respect to any proposal (the “Voting Cap”).

     

     
     

     

    Dividends

     

    Holders of shares of the Series A Preferred Stock are entitled to receive, when, as and if authorized by the Board and declared by the Company, out of funds of the Company legally available for the payment of dividends, cumulative cash dividends in an amount for each share of Series A Preferred Stock equal to 5% per annum (the “Dividend Rate”) multiplied by $1,000 (the “Stated Value”). Dividends on the Series A Preferred Stock shall accrue daily and be cumulative from, and including, the date of original issue and shall be payable quarterly in arrears on the 15th day of March, June, September and December of each year (each, a “Dividend Payment Date”), starting March 15, 2025; provided, that if any Dividend Payment Date is not a business day, then the dividend which would otherwise have been payable on that Dividend Payment Date may be paid on the next succeeding business day with the same force and effect as if paid on such Dividend Payment Date and no interest, additional dividends or other sums will accrue on the amount so payable for the period from and after such Dividend Payment Date to such next succeeding business day. Any dividend payable on the Series A Preferred Stock, including dividends payable for any partial dividend period, will be computed on the basis of a 360-day year consisting of twelve 30-day months.

     

    Liquidation Preference

     

    Upon any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary (a “Liquidation”), the holders shall be entitled to receive out of the assets, whether capital or surplus, of the Company an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon (whether declared or not declared) and any other fees or liquidated damages then due and owing thereon, for each share of Series A Preferred Stock before any distribution or payment shall be made to the holders of any of the Common Stock and all other Common Stock equivalents of the Company other than those securities (i) which are explicitly senior or pari passu to the Series A Preferred Stock, or (ii) to which the Series A Preferred Stock is explicitly junior in dividend rights or liquidation preference (the “Junior Securities”) or other capital stock, and if the assets of the Company shall be insufficient to pay in full such amounts, then the entire assets to be distributed to the holders shall be ratably distributed among the holders in accordance with the respective amounts that would be payable on such shares if all amounts payable thereon were paid in full. The Company shall mail written notice of any such Liquidation, not less than 45 days prior to the payment date stated therein, to each holder.

     

    Conversion Rights

     

    Each share of Series A Preferred Stock shall be convertible, at any time and from time to time from and after the original issue date at the option of the holder thereof, into that number of shares of Common Stock determined by dividing the Stated Value of such share of Series A Preferred Stock, plus any accrued and unpaid dividends thereon (whether declared or not declared), by the higher of $0.01 or 90% of the average VWAP of the five trading days immediately prior to the date the conversion notice is tendered by the holder (the “Conversion Price”).

     

    The summary of the rights, privileges and preferences of the Series A Preferred Stock described above is qualified in its entirety by reference to the Certificate of Designation, a copy of which is attached as Exhibit 3.1 to this Current Report on Form 8-K and are incorporated herein by reference.

     

    Item 7.01 Regulation FD Disclosure.

     

    The Company desires to provide an update on various legal proceedings below:

     

    Illumina, Inc.

     

    On June 21, 2024, Illumina, Inc. secured a judgment for $821,670.40 against the Company for non-payment of services rendered. The Company is in discussions with Illumina to reach a settlement of this liability and hopes to secure a settlement agreement to satisfy the debt by exchanging it for equity in the Company. The liability is included and disclosed in the Company’s prior financial statements. The Company cannot guarantee a successful outcome to current discussions and will continue to record the full liability in its financial statements.

     

     
     

     

    Senior PIK Notes

     

    On July 17, 2024, two holders of issued 15% Senior Promissory Notes issued by the Company in the aggregate principal amount of $3,458,000 (the “Senior PIK Notes”) initiated legal action against the Company for non-payment of amounts due under the Senior PIK Notes. The legal actions are for $378,625 and $757,250, respectively.

     

    On October 18, 2024, the Company received the approval of over 50.01% of the holders of the Senior PIK Notes based on the Aggregate Original Principal Amount (as defined in the Senior PIK Notes) to enter into Amendment No. 1 to the Senior PIK Notes (the “Amendment”). Pursuant to the Amendment, the Senior PIK Notes will be automatically exchanged into shares of the Company’s Series B Cumulative Convertible Redeemable Preferred Stock, to be designated (the “Series B Preferred Stock”) effective as of 5:00 pm Eastern time on the second business day after the date on which the Company’s stockholders approve the conversion of the Series B Preferred Stock into shares of Class A Common Stock in accordance with the continued listing rules of the New York Stock Exchange American. The Senior PIK Notes (not including accrued and unpaid Interest (as defined in the Senior PIK Notes) which will be waived as part of the automatic exchange) will automatically exchange into a number of shares of Series B Preferred Stock equal to the Original Principal Amount (as defined in the Senior PIK Notes) divided by the Stated Value ($1,000) of the Series B Preferred Stock (the “Automatic Exchange”). Upon the Automatic Exchange, all Senior PIK Notes (including all accrued and unpaid Interest) (which total value was $4,706,628.92 at June 30, 2024) shall be exchanged to equity, cancelled and satisfied in full. No shares of Series B Preferred Stock will be convertible into Class A Common Stock prior to the one-year anniversary of the date of issuance. Each share of Series B Preferred Stock will have one vote.

     

    The Company believes that this amendment will lead to settlement of the legal actions described above under the subheading “Senior PIK Notes.”

     

    Item 9.01 Financial Statements and Exhibits.

     

    (d) Exhibits.

     

    Exhibit

    Number

      Description of Exhibit
    3.1   Certificate of Designation filed with the Delaware Secretary of State on October 18, 2024
    104   Cover Page Interactive Data File (formatted in Inline XBRL)

     

     
     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      FOXO Technologies Inc.
         
    Date: October 23, 2024 By: /s/ Mark White
      Name: Mark White
      Title: Interim Chief Executive Officer

     

     

     

    Get the next $FOXO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FOXO

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $FOXO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Langley Trevor claimed ownership of 1,023,629 shares (SEC Form 3)

    3 - FOXO TECHNOLOGIES INC. (0001812360) (Issuer)

    9/12/24 5:28:21 PM ET
    $FOXO
    Life Insurance
    Finance

    New insider Lagan Seamus claimed ownership of 1,023,629 shares (SEC Form 3)

    3 - FOXO TECHNOLOGIES INC. (0001812360) (Issuer)

    9/12/24 5:27:29 PM ET
    $FOXO
    Life Insurance
    Finance

    Large owner Kr8 Ai Inc. sold $325,000 worth of shares (1,300,000 units at $0.25), closing all direct ownership in the company (SEC Form 4)

    4 - FOXO TECHNOLOGIES INC. (0001812360) (Issuer)

    7/24/24 4:00:23 PM ET
    $FOXO
    Life Insurance
    Finance

    $FOXO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    FOXO Technologies Inc. Subsidiary, Big South Fork Medical Center, Expands Clinical Capabilities

    WEST PALM BEACH, FL, Jan. 20, 2026 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (OTC:FOXO) ("FOXO" or the "Company") today announced that its critical access-designated acute care hospital, Scott County Community Hospital, Inc. (d/b/a Big South Fork Medical Center), has expanded its clinical capabilities through the addition of inpatient tele-specialty services and cardiac diagnostics. In partnership with Rural Physicians Group, Big South Fork Medical Center now provides inpatient tele-specialty coverage in cardiology, pulmonology, and nephrology, enabling more patients to receive specialty evaluation and treatment locally. The hospital has historically transferred out a number of patients

    1/20/26 8:07:00 AM ET
    $FOXO
    Life Insurance
    Finance

    FOXO TECHNOLOGIES INC. CEO SEAMUS LAGAN PROVIDES YEAR-END REVIEW TO SHAREHOLDERS

    WEST PALM BEACH, FL, Dec. 15, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (OTC:FOXO) (the "Company"), announces Chief Executive Officer Seamus Lagan has provided the following Year-End Review to shareholders: FOXO Shareholders: As we rapidly approach year-end, I wanted to reach out to our shareholders to review key milestones of 2025 and preview our go-forward operating and growth strategy. Much of the foundation of the "new" FOXO was created in mid-2024 when the Company acquired both Myrtle Recovery Centers, Inc. and Rennova Community Health, Inc. (including its principal subsidiary, Scott County Community Hospital, Inc.). More recently, we expanded our portfolio of healthcare-relat

    12/15/25 8:07:00 AM ET
    $FOXO
    Life Insurance
    Finance

    FOXO Technologies Inc. Subsidiary, Myrtle Recovery Centers, Recognized by the Rural Health Association of Tennessee for Outstanding Community Impact

    WEST PALM BEACH, FL, Dec. 09, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (OTC:FOXO) ("FOXO" or the "Company") today announced that its behavioral health subsidiary, Myrtle Recovery Centers, Inc., was recently recognized by the Rural Health Association of Tennessee ("RHA") at their Awards Luncheon during the Annual RHA Conference. RHA celebrated Myrtle's ongoing engagement, willingness to share lessons learned, and its service to communities across Tennessee. The recognition comes after Myrtle celebrated two years of accepting patients in August marked by serving individuals from 63 of Tennessee's 95 counties reflecting the statewide need for accessible, recovery-focused care. "This

    12/9/25 8:07:00 AM ET
    $FOXO
    Life Insurance
    Finance

    $FOXO
    SEC Filings

    View All

    FOXO Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - FOXO TECHNOLOGIES INC. (0001812360) (Filer)

    2/6/26 5:05:52 PM ET
    $FOXO
    Life Insurance
    Finance

    SEC Form SCHEDULE 13G filed by FOXO Technologies Inc.

    SCHEDULE 13G - FOXO TECHNOLOGIES INC. (0001812360) (Subject)

    1/21/26 7:54:49 AM ET
    $FOXO
    Life Insurance
    Finance

    FOXO Technologies Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - FOXO TECHNOLOGIES INC. (0001812360) (Filer)

    1/20/26 5:10:42 PM ET
    $FOXO
    Life Insurance
    Finance

    $FOXO
    Financials

    Live finance-specific insights

    View All

    FOXO TECHNOLOGIES INC. CEO SEAMUS LAGAN PROVIDES YEAR-END REVIEW TO SHAREHOLDERS

    WEST PALM BEACH, FL, Dec. 15, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (OTC:FOXO) (the "Company"), announces Chief Executive Officer Seamus Lagan has provided the following Year-End Review to shareholders: FOXO Shareholders: As we rapidly approach year-end, I wanted to reach out to our shareholders to review key milestones of 2025 and preview our go-forward operating and growth strategy. Much of the foundation of the "new" FOXO was created in mid-2024 when the Company acquired both Myrtle Recovery Centers, Inc. and Rennova Community Health, Inc. (including its principal subsidiary, Scott County Community Hospital, Inc.). More recently, we expanded our portfolio of healthcare-relat

    12/15/25 8:07:00 AM ET
    $FOXO
    Life Insurance
    Finance

    FOXO TECHNOLOGIES INC. DESIGNATES NEW SERIES OF PREFERRED STOCK TO BE USED FOR ACQUISITIONS

    WEST PALM BEACH, FLORIDA, June 27, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE:FOXO) ("FOXO" or the "Company") today announced that it has designated a new series of its preferred stock (Series E Cumulative Redeemable Secured Preferred Stock e (the "Series E Preferred Stock")) and filed the series' certificate of designation with the Secretary of State of Delaware. The newly designated series of preferred stock includes: (i) a stated value of $25.00 per share, (ii) a 2.5% per annum cash dividend paid semi-annually, (iii) a 5.0% per annum common stock dividend paid semi-annually, and (iv) a security interest in the stock of the Company's recently formed acquisition vehicle, FOXO A

    6/27/25 7:27:00 AM ET
    $FOXO
    Life Insurance
    Finance

    FOXO TECHNOLOGIES, INC., PROVIDES UPDATE ON RECENT ACOMPLISHMENTS AND BUSINESS STRATEGY

    MINNEAPOLIS, MN, Jan. 28, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the "Company"), provides a brief shareholder letter from Seamus Lagan, recently appointed CEO of FOXO on what has been achieved in recent months and what is planned for 2025 and beyond. Dear Fellow Shareholders, Our recent shareholders meeting on January 17th concluded the requirements of 2024 acquisition agreements and resulted in a change of control of the Company. The accomplishments in the second half of 2024 have been key to what we believe is becoming a very successful turnaround of our Company and has created a foundation from which we believe we can build a significant and profitable

    1/28/25 8:05:00 AM ET
    $FOXO
    Life Insurance
    Finance

    $FOXO
    Leadership Updates

    Live Leadership Updates

    View All

    FOXO TECHNOLOGIES INC.'S BIG SOUTH FORK MEDICAL CENTER COMPLETES PERFORMANCE NETWORK AGREEMENT WITH COVENANT HEALTH TO PROVIDE SWING BED SERVICES

    WEST PALM BEACH, FLORIDA, Aug. 01, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE:FOXO) ("FOXO" or the "Company") today announced that its critical access designated rural hospital, Big South Fork Medical Center located in Oneida, Tennessee, has completed a Performance Network Agreement with Covenant Health to join their performance network as a provider of swing bed services. Covenant Health is a large, muti-facility hospital network serving greater Knoxville and East Tennessee. Patients who no longer meet acute care admission criteria are frequently in need of post-acute care to enhance their recovery. Big South Fork Medical Center is well positioned to provide swing bed services

    8/1/25 7:52:00 AM ET
    $FOXO
    Life Insurance
    Finance

    FOXO TECHNOLOGIES INC. CREATES ACQUISITION VEHICLE AND APPOINTS NEW INTERIM CFO

    WEST PALM BEACH, FLORIDA, June 16, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE:FOXO) ("FOXO" or the "Company") today announced that it formed a new, wholly-owned subsidiary intended to be used to acquire identified acquisition targets in the healthcare services and related sectors. On June 13, 2025, the Company formed FOXO Acquisition Corporation, a Florida corporation, for the purpose of acquiring targeted acquisitions. The Company also intends to create a new series of non-convertible preferred stock with a goal to have this preferred stock publicly listed (with its own trading symbol) and use it to as a mechanism to complete such acquisitions. The new series of preferred stoc

    6/16/25 7:43:00 AM ET
    $FOXO
    Life Insurance
    Finance

    FOXO TECHNOLOGIES INC. ANNOUNCES RESTRUCTURING AND CAPITAL RAISING TRANSACTIONS AND APPOINTS SEAMUS LAGAN AS CHIEF EXECUTIVE OFFICER

    MINNEAPOLIS, MN, Dec. 11, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the "Company" or "FOXO") announces a series of restructuring and capital raising transactions which will improve the Company's balance sheet, satisfy minimum stockholders' equity requirements of the NYSE American and provide capital for growth and reduce outstanding liabilities. The Company also announces a change in senior leadership. Key transactions include: Rennova Health, Inc.'s exchange of approximately $21 million of a Senior Secured Note issued by Rennova Community Health, Inc., the Company's subsidiary, into 21,000 shares of the Company's Series A Cumulative Convertible Redeemable Pr

    12/11/24 8:00:00 AM ET
    $FOXO
    Life Insurance
    Finance

    $FOXO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by FOXO Technologies Inc.

    SC 13G/A - FOXO TECHNOLOGIES INC. (0001812360) (Subject)

    11/7/24 8:46:01 AM ET
    $FOXO
    Life Insurance
    Finance

    Amendment: SEC Form SC 13D/A filed by FOXO Technologies Inc.

    SC 13D/A - FOXO TECHNOLOGIES INC. (0001812360) (Subject)

    9/23/24 4:15:07 PM ET
    $FOXO
    Life Insurance
    Finance

    SEC Form SC 13D filed by FOXO Technologies Inc.

    SC 13D - FOXO TECHNOLOGIES INC. (0001812360) (Subject)

    8/5/24 4:15:29 PM ET
    $FOXO
    Life Insurance
    Finance